Auto-inflammatory syndromes;Les syndromes auto-inflammatoires

Revue du Praticien

Volumn 55, Issue 4, 2005, Pages 353-359

  Grateau, Gilles ^a,b  

^a HÔPITAL TENON   (France)

^b INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; INTERLEUKIN 1 ANTIBODY; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AMYLOIDOSIS; AUTOINFLAMMATORY DISEASE; CINCA SYNDROME; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFLAMMATORY DISEASE; REVIEW; SKIN MANIFESTATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

AUTOIMMUNE DISEASES; DIAGNOSIS, DIFFERENTIAL; FAMILIAL MEDITERRANEAN FEVER; HUMANS; INFLAMMATION; RISK FACTORS; SYNDROME;

EID: 14744295577     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Grateau G. Musculoskeletal disorders in secondary amyloidosis and hereditary fevers. Best Pract Res Clin Rheumatol 2003; 17: 929-44.
2. Dode C, Andre M, Bienvenu T et al. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheur 2002; 46: 2181-8.
3. Grateau G, Cazeneuve C, Papin S et al. Amylose et auto-inflammation. In: Lesavre P, Drüeke T, Legendre C, Niaudet P (eds). Actualités néphrologiques Jean Hamburger. Paris: Flammarion Médecine- Sciences, 2004: 33-48.
4. Duzova A, Bakkaloglu A, Besbas N et al. Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 2003; 21: 509-14.
5. Cazeneuve C, Ajrapetyan H, Papin S et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 1136-43.
6. A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 1997; 17 h25-31.
7. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807.
8. Gumucio DL, Diaz A, Schaner P et al. Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol 2002; 20 (4 Suppl. 26): S45-S53.
9. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-5.
10. Gostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319-25.
11. McDermott MF, Akesentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999; 97: 133-44.
12. Huggins ML, Radford PM, McIntosh RS et al. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum 2004; 50: 2651-9.
13. Drenth JP, Cuisset L, Grateau G et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 1999; 22: 178-81.
14. Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 2002; 11: 3115-24.
15. Zemer D, Pras M, Sonar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 1001-5.
16. Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford) 2003; 42: 235-9.
17. Drewe E, Huggins ML, Morgan AG, Cassidy MJ, Powell RJ. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford) 2004; 43: 1405-8.
18. Hawkins PH, Lachmann HJ, Aganna E, McDermott UF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004; 50: 607-12.
19. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003; 348: 2583-4.
20. Hoffman HM, Rosengren S, Boyle DL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364: 1779-85.
21. Simon A, Drewe E, van der Meer JW et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 2004; 75: 476-83.
22. Hull KM, Drewe E, Aksentijevich I et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 2002; 81: 349-68.